Erectile dysfunction (ED) is a common complaint in general medical practice.1
Prevalence of partial or complete ED is 50% in men aged 40 to 70, and prevalence increases with aging.2
Erectile dysfunction is generally related to vascular, neurologic, psychologic, and hormonal disorders.2
Tadalafil is a safe, well tolerated, and efficacious treatment for most severities and aetiologies of Erectile dysfunction.3
References: 1. Yovwin DG, Imarhiagbe FA, Obazee EM, Oguike TC. Erectile dysfunction in a sub-saharan African population: Profile and correlates in a tertiary care hospital. Sahel Medical Journal 2015; 18(3):116-120. 2. Hirsch IH. Erectile Dysfunction – MSD Manual Professional Version. Available at: https://www.msdmanuals.com/professional/genitourinary-disorders/male-sexual-dysfunction/erectile-dysfunction?query=Erectile%20Dysfunction%20(ED)#. Accessed 25 November 2021. 3. Coward RM, Carson CC. Tadalafil in the treatment of erectile dysfunction. Therapeutics and Clinical Risk Management 2008; 4(6):1315-1329. 4. De Tejada IS, Anglin G, Knight JR, Emmick JT. Effects of Tadalafil on Erectile Dysfunction in Men With Diabetes. Diabetes Care 2002; 25:2159-2164. 5. TALVIOR 5 Professional Information (April 2020). 6. TALVIOR 20 Professional Information (April 2020). 7. Gong B, Ma M, Xie W, et al. Direct comparison of tadalafil with sildenafil for the treatment of erectile dysfunction: a systematic review and meta-analysis. Int Urol Nephrol 2017; 49:1731-1740. 8. Data on file.